The Alliance for Connected Care submitted comments to HHS's request for comments on policy priorities to advance care for substance use disorder (SUD) under the Great American Recovery Initiative. Telehealth is uniquely equipped to expand and scale behavioral health care, especially for prevention and treatment. The Alliance urged HHS to work with the Drug [...]
The Alliance for Connected Care and over 150 stakeholders sent a letter to CMS thanking the agency for its leadership in creating location reporting flexibility for practitioners with an in-person practice location. In addition to this recognition, signers request that CMS begin work on a low-burden means of addressing these concerns for fully remote [...]
The Alliance for Connected Care led over 180 health care providers, innovators, and advocates in urging the Office of Management and Budget (OMB) and Drug Enforcement Administration (DEA) to advance a telemedicine regulation (RIN: 1117-ZA07) continuing access to prescribing through telehealth. Without action, these critical telemedicine authorities will expire on December 31, 2025; patients [...]
The Alliance for Connected Care led a letter signed by over 200 organizations in a letter to Terry Cole, Administrator of the Drug Enforcement Administration (DEA), requesting his leadership in ensuring that millions of Americans continue to have access to medically necessary health care through telemedicine after the current access deadline of December 31, [...]
The Alliance for Connected Care submitted input on the Office of National Drug Control Policy’s 2026 National Drug Control Strategy. The Alliance emphasized the importance of maintaining comprehensive access to telehealth, because it is often an essential part of treatment for mental health conditions and substance use disorders and supports long-term recovery. The Alliance urged ONDCP [...]
The Alliance submitted a response to the Department of Justice Anticompetitive Regulations Task Force request for public comment to identify unnecessary laws and regulations that raise the highest barriers to competition. The Alliance for Connected Care (the “Alliance”) outlines four areas where we hope the Department of Justice Task Force will focus to improve care [...]
The Alliance submitted a response to the Federal Trade Commission's request for public comment regarding reducing anti-competitive regulatory barriers in health care. Our health care system is deeply impacted by anticompetitive practices. The Alliance appreciates the Federal Trade Commission’s long-standing work to reform occupational licensing regulations, removing anticompetitive practices. In particular, the FTC investigated options [...]
The Alliance appreciates the DEA’s forward movement on telemedicine prescribing of controlled substances policy. However, the Alliance continues to be concerned to see language in the proposed rulemaking mandating in-person visits as this is not an appropriate guardrail for a telehealth service. Similarly, restricting the geography in which telemedicine can be offered undermines the value [...]
If the DEA or Congress fail to enact an operationally feasible regulation for controlled substance prescribing via telehealth, thousands of patients risk losing access to vital, clinically appropriate medications. This could disrupt the care of patients dependent on remotely prescribed medications from a provider with whom they don’t have an in-person relationship (e.g. e-prescribed [...]
The Alliance for Connected Care led a letter, signed by more than 150 organizations, to the Attorney General Pam Bondi requesting her leadership in maintaining the access to telehealth that President Trump initiated during his first term. More than 150 organizations have signed this letter, including business groups like the Small Business & Entrepreneurship Council and [...]